Pharmaceutical Price Regulation Scheme

Department of Health and Social Care written question – answered on 5th September 2018.

Alert me about debates like this

Photo of Darren Jones Darren Jones Labour, Bristol North West

To ask the Secretary of State for Health and Social Care, if he will make it his policy to maintain the current cost-effectiveness threshold per quality-adjusted life year in the next Pharmaceutical Price Regulation Scheme.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective innovative medicines and technologies at a price the National Health Service can afford. We have been listening to industry feedback and discussing how the medicines market is likely to evolve over the next five years. These discussions have now moved into a more formal phase and are commercially sensitive. The Government will update Parliament if and when agreement is reached.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.